Frankfurt
02.04.26 | 21:48
1,730 Euro
+0,29 % +0,005
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Navamedic ASA: Notice of Annual General Meeting | 1 | Oslo Børs | ||
| 25.03. | Navamedic ASA: Annual Report 2025 | 1 | Oslo Børs | ||
| NAVAMEDIC Aktie jetzt für 0€ handeln | |||||
| 27.02. | Navamedic ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
| 09.02. | Navamedic ASA: Invitation to presentation of fourth quarter 2025 results | 1 | Oslo Børs | ||
| 19.01. | Navamedic ASA: Financial calendar | 1 | Oslo Børs | ||
| 07.01. | Navamedic ASA: Minutes of Extraordinary General Meeting | 1 | Oslo Børs | ||
| 29.12.25 | Navamedic ASA: Grete Roede og Navamedic lanserer nytt vektreduksjonskonsept: Lettere steg | 1 | Oslo Børs | ||
| 18.12.25 | Navamedic ASA: Financial calendar | - | Oslo Børs | ||
| 12.12.25 | Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026 | 1 | Oslo Børs | ||
| 09.12.25 | Oslo, December 9, 2025 - Navamedic ASA Introduces Flexilev[] in OraFID[]: Enhancing Parkinson's Care with Simplified and Precise Dosing for Personalized Treatment | 3 | Oslo Børs | ||
| 09.12.25 | Oslo, December 9, 2025 - Navamedic ASA Introduces Flexilev in OraFID: Enhancing Parkinson's Care with Simplified and Precise Dosing for Personalized Treatment | 2 | Cision News | ||
| 08.12.25 | Navamedic ASA: Appointment of CFO | - | Oslo Børs | ||
| 28.11.25 | Navamedic ASA: Resignation of CFO | 2 | Oslo Børs | ||
| 28.10.25 | Navamedic ASA: Double digit growth in the 3rd quarter, 2025 | 373 | PR Newswire | OSLO, Norway, Oct. 28, 2025 /PRNewswire/ -- In the third quarter 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of high-quality prescription, consumer... ► Artikel lesen | |
| 24.10.25 | Navamedic ASA: Invitation to 2025 3rd quarter presentation | 1 | Cision News | ||
| 17.10.25 | Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical | 1 | Oslo Børs | ||
| 15.10.25 | Navamedic ASA: NOTIFICATION OF MAJOR HOLDINGS | - | Oslo Børs | ||
| 14.10.25 | Navamedic ASA: Flaggemelding NAVA | - | Oslo Børs | ||
| 13.10.25 | Navamedic ASA - New share capital registered | 3 | Cision News | ||
| 07.10.25 | Navamedic ASA: Notification of major shareholding | - | Oslo Børs |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DERMAPHARM | 47,250 | +1,72 % | EQS-News: Dermapharm Holding SE verzeichnet Umsatzrückgang, bereinigtes Konzern-EBITDA und Marge steigen | EQS-News: Dermapharm Holding SE
/ Schlagwort(e): Jahresergebnis/Jahresbericht
Dermapharm Holding SE verzeichnet Umsatzrückgang, bereinigtes Konzern-EBITDA und Marge steigen
31.03.2026... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,975 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly Food Group's Yolks Breakfast Signs Franchise Agreement and Secures Real-Estate Location in the City of Port Moody, British Columbia | Toronto, Ontario--(Newsfile Corp. - March 31, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFG) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen | |
| CANTOURAGE GROUP | 4,440 | -4,52 % | Original-Research: Cantourage Group SE (von NuWays AG): BUY | Original-Research: Cantourage Group SE - from NuWays AG
18.03.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible... ► Artikel lesen | |
| BACHEM | 72,70 | -0,07 % | Bachem FY25 Earnings Rise; Proposes Dividend Increase; Guides FY26 | WASHINGTON (dpa-AFX) - Bachem Holding AG (BCHMY, BCHMF), a Swiss biotechnology company, on Thursday reported higher full-year 2025 net income compared with the previous year, proposed a dividend... ► Artikel lesen | |
| ZEALAND PHARMA | 40,330 | +0,07 % | Total number of shares and voting rights in Zealand Pharma as of March 31, 2026 | ||
| PHARMASGP | 28,800 | 0,00 % | PharmaSGP: Abfindungshöhe wird verändert | Am 31. Oktober findet bei PharmaSGP eine außerordentliche Hauptversammlung statt. Dort soll über den Squeeze-out der verbliebenen Minderheitsaktionäre entschieden werden. Die Futrue GmbH als Hauptaktionärin... ► Artikel lesen | |
| APONTIS PHARMA | 11,000 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 14.11.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 14.11.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 14.11.2025ISIN NameCA3837981057 GOVIEX... ► Artikel lesen | |
| POLYPEPTIDE GROUP | 31,800 | -2,45 % | PolyPeptide Group: PolyPeptide strengthens financing structure through expansion of existing credit facility | PolyPeptide Group
/ Key word(s): Financing
PolyPeptide strengthens financing structure through expansion of existing credit facility
19.03.2026 / 07:00 CET/CEST
Media... ► Artikel lesen | |
| PHOTOCURE | 5,090 | 0,00 % | Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway | OSLO, Norway, March 16, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two "trial in progress" presentations at the 2026 European Association of Urology... ► Artikel lesen | |
| ARCTICZYMES TECHNOLOGIES | 1,730 | -0,29 % | Brenntag Signs Exclusive Distribution Deal With ArcticZymes | MUEHLHEIM (dpa-AFX) - Brenntag SE (BNTGF.PK), Wednesday announced an exclusive distribution agreement with ArcticZymes AS on the salt-active nucleases - SAN HQ, SAN-HQ GMP, M-SAN HQ, M-SAN HQ... ► Artikel lesen | |
| ZELLUNA | 1,744 | +4,93 % | Zelluna ASA: Zelluna announces collaboration with Etcembly for AI-enabled TCR engineering | Oslo, Norway, 09 March 2026 - Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers,... ► Artikel lesen | |
| AQUA BIO TECHNOLOGY | 0,612 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 27.02.2026 | The following instruments on XETRA do have their first trading 27.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 27.02.2026
Aktien
1 HK0000356805 Lai Sun Garment [International]... ► Artikel lesen | |
| VISTIN PHARMA | 1,915 | 0,00 % | Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results | Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and preliminary results of 2025. Solid last quarter of 2025 signs-off a record... ► Artikel lesen |
Das Unternehmen NAVAMEDIC ASA kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 1,730 Euro und damit +0,29 % im Plus. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NAVAMEDIC ASA finden Sie auf Wallstreet Online.